Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $43,080 - $65,679
359 Added 2.42%
15,219 $1.92 Million
Q1 2024

May 14, 2024

BUY
$170.78 - $208.42 $802,324 - $979,157
4,698 Added 46.23%
14,860 $2.73 Million
Q4 2023

Feb 13, 2024

BUY
$114.17 - $185.35 $1.16 Million - $1.88 Million
10,162 New
10,162 $1.83 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Apg Asset Management Us Inc. Portfolio

Follow Apg Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management Us Inc. with notifications on news.